• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Disord Drug Targets . Current Treatments and Therapeutic Options for COVID-19 Patients: A Systematic Review

tetano

Editor, Senior Moderator
Infect Disord Drug Targets


. 2021 Jul 26.
doi: 10.2174/1871526521666210726150435. Online ahead of print.
Current Treatments and Therapeutic Options for COVID-19 Patients: A Systematic Review


Esmaeil Mehraeen[SUP] 1 [/SUP], Zeinab Najafi[SUP] 2 [/SUP], Bagher Hayati[SUP] 3 [/SUP], Mohammad Javaherian[SUP] 4 [/SUP], Sajad Rahimi[SUP] 3 [/SUP], Omid Dadras[SUP] 5 [/SUP], SeyedAhmad SeyedAlinaghi[SUP] 2 [/SUP], Maryam Ghadimi[SUP] 6 [/SUP], Jean-Marc Sabatier[SUP] 7 [/SUP]



Affiliations

Abstract

Introduction: COVID-19 is the third rising epidemic in the 21st century that quickly turned into a worldwide pandemic. Many clinical studies have been achieved to investigate treatments to confrontation of COVID-19. Therefore, we conducted a systematic reviewto describe the recent treatment strategies to treat COVID-19 patients.
Methods: A systematic search was performed in the databases of PubMed, Scopus, Embase, Science direct, Up to date, and Web of Science using the keywords of Coronavirus, COVID-19, SARS-CoV-2, Novel Coronavirus, 2019-nCoV, Treatment, Medicine, Therapy, Intervention, Drug, Medications, and Cure.
Results: We included 58 studies including 38 articles (eleven reviews, ten editorial documents, three case reports, one mix method, one cohort study,) and 19 published clinical trials. Review of studies showed that Lopinavir/Ritonavir (n=16), Remdesivir (n=13), Convalescent plasma (n=11), Chloroquine (n=11), Ribavirin (n=9), Hydroxychloroquine sulfate (n=8), Traditional Chinese Medicine (TCM) (n=8), and Arbidol (n=7), were the most frequently used therapies used to treat COVID-19 patients.
Conclusion: In the absence of definitive treatment protocols, recently proposed approaches appear to be an effective therapy for accelerating the recovery of COVID-19 patients. Some of these treatments may have been in the early stages of testing. However, future preclinical and clinical trials are warranted to validate findings.

Keywords: Antiviral; COVID-19; COVID-19 Therapy; Coronavirus; Intervention; Medicine; Treatment.
 
Back
Top Bottom